Lung Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology
See more in Biomedtracker

Latest on Lung Therapeutics, Inc.

Scrip

Asia Deal Watch: LianBio Partners With Pfizer In Greater China, Gets Financial Backing

 
• By Joseph Haas, Ian Haydock, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. LianBio Adds Pfizer To Initial Tie-Ups

Scrip

Venture Funding Deals: Locana Gets Ready To Take On ALS, Huntington's With Gene Editing

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions , Informa's premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

Scrip

Finance Watch: Third Rock Raises $770m To Launch Up To 12 New Companies

 
• By Mandy Jackson and Jung Won Shin

Third Rock Ventures LLC launched more than 50 biopharma, device and diagnostic companies with its first four venture capital funds, and with its fifth and largest – the $770m Third Rock Ventures V LP

Scrip

Venture Funding Deals: $688.8m In Financings From Avitide To Zai Lab

 
• By Deanna Kamienski, Beth Allan, Maureen Riordan, and Steven Muntner

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio